Innervace Secures Up to $40 Million to Advance Novel Regenerative Medicine Platform for Neurological Disorders
Press Release Innervace Secures Up to $40 Million to Advance Novel Regenerative Medicine Platform for Neurological Disorders Series A financing round, led by Deerfield Management, to accelerate a new cell therapy modality Read More »
